Log In
Print this Print this

FE 999301 (formerly FE301)

  Manage Alerts
Collapse Summary General Information
Company Conaris Research Institute AG
DescriptionInterleukin-6 (IL-6) receptor (CD126) antagonist
Molecular Target Interleukin-6 (IL-6) receptor (CD126)
Mechanism of ActionInterleukin-6 (IL-6) receptor antagonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationCrohn's disease
Indication DetailsTreat Crohn's disease
Regulatory Designation
PartnerFerring Pharmaceuticals A/S

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today